Tak-715 Chemical Properties

storage temp. 

Sealed in dry,2-8°C

solubility 

DMSO: >15mg/mL

form 

powder

color 

faint yellow to dark yellow

InChI

InChI=1S/C24H21N3OS/c1-3-21-27-22(18-11-7-8-16(2)14-18)23(29-21)19-12-13-25-20(15-19)26-24(28)17-9-5-4-6-10-17/h4-15H,3H2,1-2H3,(H,25,26,28)

InChIKey

HEKAIDKUDLCBRU-UHFFFAOYSA-N

SMILES

C(NC1=NC=CC(C2SC(CC)=NC=2C2=CC=CC(C)=C2)=C1)(=O)C1=CC=CC=C1

Safety Information

Hazard Codes 

Xn

Risk Statements 

22-36

Safety Statements 

26

WGK Germany 

3

HS Code 

2934999090

Tak-715 Usage And Synthesis

Uses

TAK 715 is a p38 MAPK inhibitor for p38α and p38β but not for p38γ and p38δ.

Definition

ChEBI: N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]benzamide is a member of benzamides.

Biological Activity

tak-715 is a selective inhibitor of p38 mapk with ic50 value of 7.1 nm [1].p38 mitogen-activated protein (map) kinases (p38 mapks) are a class of mitogen-activated protein kinases and play an important role in controlling cellular responses to cytokines and stress. four p38 mapks contain members, p38-α (mapk14), p38-β (mapk11), p38-γ (mapk12/erk6), and p38-δ (mapk13/sapk4), have been identified. abnormal expression of p38 mapks are correlated with a variety of chronic inflammatory diseases and their inhibitors are regarded as promising targets in clinical [1] [2].tak-715 is a potent p38 mapk inhibitor and has a different selectivity with the reported p38 mapk inhibitor vx-745. when tested with human monocytic thp-1 cells, administration of tak-715 exhibited inhibition on p38mapkα with ic50 value of 7.1 nm [1]. in hek293t, u2os, and f9 cells, tak-715 was used to inhibit p38 mapk activity and concluded that p38 mapk had no function in wnt/β-catenin signaling pathway [2].in adjuvant-induced rheumatoid arthritis rat model, administration of tak-715 at dose of 10 mg/kg significantly decreased lps-induced stimulated release of tnf-α (87.6%) by inhibiting p38 mapk activity [1].

in vivo

IC 50

p38α: 7.1 nM (IC₅₀); p38β: 200 nM (IC₅₀); p38δ: >10 μM (IC₅₀); p38γ: >10 μM (IC₅₀); CK1δ; CK1ε

storage

+4°C

References

[1]. miwatashi, s., et al., novel inhibitor of p38 map kinase as an anti-tnf-alpha drug: discovery of n-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (tak-715) as a potent and orally active anti-rheumatoid arthritis agent. j med chem, 2005. 48(19): p. 5966-79.
[2]. verkaar, f., et al., inhibition of wnt/beta-catenin signaling by p38 map kinase inhibitors is explained by cross-reactivity with casein kinase idelta/varepsilon. chem biol, 2011. 18(4): p. 485-94.

Tak-715(303162-79-0)Related Product Information

• 2-Aminoethyl(ethyl)amine
• N-ethyl-pyrrolidone
• N-(2-Hydroxyethyl)-2-pyrrolidone
• Saracatinib
• SB 202190
• Bardoxolone Methyl
• SB 203580
• PH 797804
• VX 702
• TAK-020
• TAK-659 (hydrochloride)
• N-Des(aMinocarbonyl) AZ-TAK1 Inhibitor